124 results on '"Porat, Yaara"'
Search Results
2. Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
3. Tumor Treating Fields (TTFields) demonstrate antiviral functions in vitro, and safety for application to COVID-19 patients in a pilot clinical study
4. Abstract 1738: Sensitizing cancer cell to doxorubicin by tumor treating fields (TTFields)-induced, elevated membrane permeability
5. Abstract 2723: Treatment of gastric cancer cells with tumor treating fields (TTFields) and concomitant FOLFOX
6. Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas
7. Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields
8. Abstract 1801: Application of Tumor Treating Fields (TTFields) to cancer cells enhances their membrane permeability
9. Abstract 2037: Spatial omic changes of malignant pleural mesothelioma following treatment using tumor-treating fields
10. Abstract 1866: Transcriptomics analysis for identification of pathways involved in the response to Tumor Treating Fields (TTFields)
11. Protocol for live-cell imaging during Tumor Treating Fields treatment with Inovitro Live
12. Enhancing membrane permeability of cancer cells through delivery of Tumor Treating Fields (TTFields)
13. inovivo - ein spezielles in vivo System zur Verabreichung von Tumor Treating Fields (TTFields) bei Mäusen
14. EXTH-74. INCREASING CANCER CELL MEMBRANE PERMEABILITY THROUGH APPLICATION OF TUMOR TREATING FIELDS (TTFIELDS)
15. EXTH-75. APPLICATION OF TUMOR TREATING FIELDS (TTFIELDS) TO THE HEAD AND TORSO OF MICE WITH THE DEDICATED INOVIVO SYSTEM
16. Abstract 1186: Efficacy of Tumor Treating Fields (TTFields) in mesothelioma is associated with reduced capacity for DNA damage repair
17. Abstract 1317: inovivo: a dedicated system for delivery of therapeutic level Tumor Treating Fields (TTFields) to mice
18. EXTH-69. INCREASED CANCER CELL PERMEABILITY FOLLOWING TUMOR TREATING FIELDS (TTFIELDS) APPLICATION IN VITRO
19. EXTH-76. THE INOVIVO SYSTEM: A NOVEL PRECLINICAL TOOL FOR IN VIVO DELIVERY OF TUMOR TREATING FIELDS (TTFIELDS)
20. Abstract 573: Efficacy of Tumor Treating Fields (TTFields) in combination with cisplatin or pemetrexed for the treatment of mesothelioma in vitro and in vivo
21. Abstract 956: Tumor treating fields (TTFields) elicit an anti-tumor immune response and in combination enhance anti-PD-1 treatment efficacy
22. Abstract 2740: The inovivo system: A novel in vivo tool for the application of Tumor Treating Fields (TTFields) to mice
23. Abstract 5848: Tumor treating fields (TTFields) induce cancer cell permeability in vitro
24. Abstract 2411: Cancer cell lines meta-analysis according to both short-term and long-term responses to Tumor Treating Fields (TTFields)
25. Abstract B14: Immunomodulatory effect of tumor treating fields (TTFields) results in enhanced antitumor efficacy when combined with anti-PD-1 therapy
26. Tumor treating fields (TTFields; 150 kHz) and FOLFOX combination treatment effects on gastric cancer in vitro.
27. Immunomodulatory effects of tumor treating fields (TTFields) on colon cancer models.
28. Die Wirkung von Tumortherapiefeldern auf die Zellmorphologie und Invasion verschiedener Tumorzellen
29. Abstract 303: The efficacy of the combined treatment of 150 kHz Tumor Treating Fields (TTFields) and FOLFOX in gastric cancer in vitro
30. Abstract 3961: Alternating electric fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
31. Abstract 1258: Pooled-analysis of response markers in cancer cell lines treated with tumor treating fields
32. Abstract 307: The combined treatment of 150 kHz Tumor Treating Fields (TTFields) and Cisplatin or Pemetrexed inhibit mesothelioma cells in vitro
33. The combined treatment of 150 kHz tumor treating fields (TTFields) and cisplatin or pemetrexed inhibits mesothelioma cells in vitro and in vivo.
34. Additional file 1: Table S1. of Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells
35. Additional file 3: Figure S2. of Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells
36. Additional file 2: Figure S1. of Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells
37. CBMT-29. INDUCTION OF AUTOPHAGY FOLLOWING TTFIELDS APPLICATION SERVES AS A SURVIVAL MECHANISM MEDIATED BY AMPK ACTIVATION
38. ANGI-11. TUMOR TREATING FIELDS (TTFIELDS) INHIBIT CANCER CELL MIGRATION AND INVASION BY INDUCING REORGANIZATION OF THE ACTIN CYTOSKELETON AND FORMATION OF CELL ADHESIONS
39. COMP-15. META-ANALYSIS OF CANCER CELL LINES BASED ON THEIR RESPONSE TO TUMOR TREATING FIELDS (TTFIELDS)
40. IMMU-52. TUMOR TREATING FIELDS (TTFIELDS) INDUCE IMMUNOGENIC CELL DEATH RESULTING IN ENHANCED ANTITUMOR EFFICACY WHEN COMBINED WITH ANTI-PD-1 THERAPY
41. AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
42. Abstract 4194: Tumor Treating Fields (TTFields) affect invasion properties and cell morphology of various cancer cells in vitro
43. Abstract 1343: Induction of autophagy following TTFields application serves as a survival mechanism mediated by AMPK activation
44. Abstract 2273: Meta-analysis of cancer cell lines based on responses to Tumor Treating Fields (TTFields)
45. Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells
46. IMMU-59. ALTERNATING ELECTRIC FIELDS (TTFIELDs) INDUCE IMMUNOGENIC CELL DEATH RESULTING IN ENHANCED ANTITUMOR EFFICACY WHEN COMBINED WITH ANTI-PD-1 THERAPY
47. CBIO-30. TUMOR TREATING FIELDS (TTFIELDS) INHIBIT CANCER CELL MIGRATION AND INVASION BY INDUCING REORGANIZING OF THE ACTIN CYTOSKELETON AND FORMATION OF CELL ADHESIONS
48. CBIO-16. INDUCTION OF AUTOPHAGY FOLLOWING TTFIELDS APPLICATION SERVES AS A SURVIVAL MECHANISM MEDIATED BY AMPK ACTIVATION
49. RBIO-07. TUMOR TREATING FIELDS (TTFIELDS) DELAY DNA DAMAGE REPAIR FOLLOWING RADIATION TREATMENT OF GLIOMA CELLS: IMPLICATIONS FOR IRRADIATION THROUGH TTFIELDS TRANSDUCER ARRAYS
50. Abstract 3665: Tumor Treating Fields (TTFields) plus anti-PD-1 therapy induce immunogenic cell death resulting in enhanced antitumor efficacy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.